This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Print page

Life Sciences & Healthcare

Clear advice in an uncertain world

The global life sciences industry continues to face periods of uncertainty, with mounting pressures experienced across the sector.

We look at issues such as increased regulation, dialogue on personalised healthcare programmes, the ubiquitous need to innovate and pricing pressures on an already challenged industry by those that end up paying the bill. 

In addition, the UK industry is having to tackle mounting challenges and competition from around the world as countries like India emerge. Our industry specialists from across Deloitte provide an extensive depth of knowledge on the range of current issues experienced by the pharmaceuticals, biotechnology, medical device and private healthcare industries.  

View our better care for frail older people report

Research and insight

  • Guideposts Dementia Information Prescription
    Post-diagnostic support is key to effective care for people with dementia and their carers. Deloitte Centre for Health Solutions evaluates one approach, Dementia Information Prescription (DIP), developed by the Guideposts Trust.
  • Routes from Diagnosis
    Macmillan’s Routes from Diagnosis research programme, in partnership with Monitor Deloitte, and Public Health England’s National Cancer Intelligence Network provides the in most detailed map of cancer survivorship yet. Read the report.
  • Real World Evidence
    Learn about how healthcare data presents a unique opportunity to develop insights which can help transform patient care.
  • Good Evidence Practice
    Building stakeholder trust in the use of health data to generate Real World Evidence for the benefit of patients.
  • Measuring the return from Pharmaceutical innovation 2013
    This Deloitte report is the fourth in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • Working differently to provide early diagnosis
    A UK Deloitte Centre for Health Solutions report which examines how healthcare commissioners and providers can work differently with the diagnostic industry and other providers to increase early diagnosis.

Useful links

  • In the press
  • Careers
  • Submit a request for proposal

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options
Follow:

Get in touch

More on Deloitte